The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2011
DOI: 10.1002/msj.20264
|View full text |Cite
|
Sign up to set email alerts
|

Strategic, Value‐Based Delivery in Global Health Care: Innovations at Harvard University and Brigham and Women's Hospital

Abstract: Investments in global health have more than doubled over the past decade, generating a cadre of new institutions. To date, most of the funded research in global health has focused on discovery, and, more recently, on the development of new tools, which has tightened the implementation bottleneck. This article introduces the concept of global health delivery and the need to catalog and analyze current implementation efforts to bridge gaps in delivery. Global health delivery is complex and context-dependent and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 21 publications
0
2
0
1
Order By: Relevance
“…It is useful to define this entire process as the POC diagnostic “value chain” ( Fig 1 ). Each link in this chain represents a potential point of failure for the entire progression from research and development to the deployment of a product that becomes part of patient care [ 50 , 51 ]. This chain includes: (i) assessments of clinical, market, and end user needs; (ii) determination of demand for the product (in part) through marketing, procurement, and partnership with local governmental and nongovernmental organizations; (iii) design and development of diagnostic assays and related devices; (iv) evaluation of product deliverability through considerations of packaging, shipping (and/or importing), storage, last mile distribution, and inventory control; (v) establishment of quality assurance and quality control processes for scaled-up manufacture of POC tests; (vi) filing for regulatory approval for the intended use of the technology in a broadly global marketplace; (vii) on-the-ground efforts towards ensuring adoption of the technology by users, clinics, and research laboratories; and (viii) organization of postdelivery support through user training, technical assistance, and maintenance of equipment.…”
Section: Introductionmentioning
confidence: 99%
“…It is useful to define this entire process as the POC diagnostic “value chain” ( Fig 1 ). Each link in this chain represents a potential point of failure for the entire progression from research and development to the deployment of a product that becomes part of patient care [ 50 , 51 ]. This chain includes: (i) assessments of clinical, market, and end user needs; (ii) determination of demand for the product (in part) through marketing, procurement, and partnership with local governmental and nongovernmental organizations; (iii) design and development of diagnostic assays and related devices; (iv) evaluation of product deliverability through considerations of packaging, shipping (and/or importing), storage, last mile distribution, and inventory control; (v) establishment of quality assurance and quality control processes for scaled-up manufacture of POC tests; (vi) filing for regulatory approval for the intended use of the technology in a broadly global marketplace; (vii) on-the-ground efforts towards ensuring adoption of the technology by users, clinics, and research laboratories; and (viii) organization of postdelivery support through user training, technical assistance, and maintenance of equipment.…”
Section: Introductionmentioning
confidence: 99%
“…[9][10][11] There are an estimated 10 million NGOs worldwide, including more than 40 000 international NGOs and thousands of local NGOs participating in health and development work in any single country. 12,13 While the benefits of NGO and government collaborations for sustainability of programs and access to care have been identified, these collaborations are contingent on a variety of factors and may not always occur. 14,15 In an era where evidencebased practice and financial accountability are drivers of healthcare, it is appropriate to examine whether NGOs operate in a way that transparently links positive and sustainable health outcomes with program implementation and spending.…”
Section: Introductionmentioning
confidence: 99%
“…Doenças crônicas, a exemplo do câncer, diabetes e as doenças cardiovasculares são as maiores causas de morte e de incapacidade no mundo. Em meio a tais doenças, ressalta-se o Infarto Agudo do Miocárdio (IAM) como uma das mais frequentes causas de busca de atendimento em serviços de urgência e hoje a causa isolada mais frequente de morte no mundo(WEINTRAUB, 2011).Nesse cenário, procurou-se desenvolver um estudo que viesse a contribuir para reduzir essas lacunas.Assim, o presente o estudo pretendeu responder à seguinte questão de pesquisa: como um hospital configura sua Cadeia de Valor a fim de ofertar serviços de saúde para combater a morbimortalidade decorrente do Infarto Agudo do Miocárdio? Diante disso, o objetivo deste estudo foi mapear a Cadeia de Valor no tratamento de infarto agudo do miocárdio.2 CADEIA DE VALORO mapeamento da Cadeia de Valor, que tradicionalmente teve suas aplicações voltadas para a manufatura, aos poucos passou a ser também usado na indústria de serviços, incluídos aí o serviço de saúde e os hospitais.…”
unclassified